Triple-Negative Myeloproliferative Neoplasms Vs. Calr, JAK2 or MPL-Mutated Myeloproliferative Neoplasms: Distinct Molecular Characteristics

被引：0
|
作者：
Yun, Jiwon [1 ]
Kim, Jung-Ah [2 ]
Hwang, Byungjin [3 ]
Park, Hee Sue [4 ]
Im, Kyongok [5 ,6 ]
Kim, Sung-Min [7 ]
Jeong, Dajeong [1 ]
Lim, Kyu Min [7 ]
Bang, Duhee [3 ]
Lee, Dong Soon [1 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Lab Med, Seoul, South Korea
[2] Chung Ang Univ Hosp, Dept Lab Med, Seoul, South Korea
[3] Yonsei Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea
[4] Chungbuk Natl Univ Hosp, Dept Lab Med, Seoul, South Korea
[5] Inst Reprod Med, Seoul, South Korea
[6] Populat Med Res Ctr, Seoul, South Korea
[7] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea
来源：
BLOOD | 2018年 / 132卷
关键词：
Myeloproliferative neoplasms; next-generation sequencing; triple negative MPN; chromosome; FISH; telomere;
D O I：
10.1182/blood-2018-99-118013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1772
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Novel modes of MPL activation in triple-negative myeloproliferative neoplasms
    Samaraweera, Saumya E.
    Geukens, Tatjana
    Casolari, Debora A.
    Nguyen, Tran
    Sun, Caitlyn
    Bailey, Sheree
    Moore, Sarah
    Feng, Jinghua
    Schreiber, Andreas W.
    Parker, Wend T.
    Brown, Anna L.
    Butcher, Carolyn
    Bardy, Peter G.
    Osborn, Michael
    Scott, Hamish S.
    Talaulikar, Dipti
    Grove, Carolyn S.
    Hahn, Christopher N.
    D'andrea, Richard J.
    Ross, David M.
    PATHOLOGY, 2023, 55 (01) : 77 - 85
  • [2] Mutations in JAK2, MPL and CALR in myeloproliferative neoplasms: High Resolution Melting analysis
    Paola Videla, Yanina
    Quintana, Silvina
    Perez Maturo, Josefina
    Di Geronimo, Vanesa
    Martin, Nazarena
    Pagani, Fernando
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2017, 51 (04): : 629 - 636
  • [3] JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science
    O Kilpivaara
    R L Levine
    Leukemia, 2008, 22 : 1813 - 1817
  • [4] JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science
    Kilpivaara, O.
    Levine, R. L.
    LEUKEMIA, 2008, 22 (10) : 1813 - 1817
  • [5] CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms
    Jorgelina Ojeda, Mara
    Margarita Bragos, Irma
    Lucrecia Calvo, Karina
    Marcela Williams, Gladis
    Magdalena Carbonell, Maria
    Flavia Pratti, Arianna
    HEMATOLOGY, 2018, 23 (04) : 208 - 211
  • [6] Frequency and Molecular Characteristics of Calreticulin Gene (CALR) Mutations in Patients with JAK2-Negative Myeloproliferative Neoplasms
    Wojtaszewska, Marzena
    Iwola, Malgorzata
    Lewandowski, Krzysztof
    ACTA HAEMATOLOGICA, 2015, 133 (02) : 193 - 198
  • [7] Correlation analysis between JAK2, MPL, and CALR mutations in patients with myeloproliferative neoplasms of Chinese Uygur and Han nationality and their clinical characteristics
    Lang, Tao
    Nie, Yuling
    Wang, Zengsheng
    Huang, Qin
    An, Li
    Wang, Yichun
    Wufuer, Guzailinuer
    Maimaiti, Aziguli
    Fu, Ling
    Li, Yan
    Zhang, Xiaoyan
    Aisimutula, Aihemaitijiang
    Wang, Xiaomin
    Zhu, Lin
    Liu, Hong
    Mao, Min
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (11) : 4650 - 4659
  • [8] Targeting JAK2 in the therapy of myeloproliferative neoplasms
    Reddy, Mamatha M.
    Deshpande, Anagha
    Sattler, Martin
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (03) : 313 - 324
  • [9] JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms
    Vannucchi, Alessandro M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (01) : 22 - 28
  • [10] JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms
    Alessandro M. Vannucchi
    Current Hematologic Malignancy Reports, 2010, 5 : 22 - 28
12345